Growing evidence supports their impact on vascular function, myocardial metabolism, renal protection, metabolic dysfunction-associated steatotic liver disease (MASLD), and systemic inflammation
Un estudio con Tirzepatide publicado a fin de 2023 mostr que, en el seguimiento de un ao, los pacientes que suspendieron el Tirzepatide tuvieron un aumento de peso significativo, fundamentalmente a expensas de ms grasa, adems de aumentar su colesterol, glucosa en sangre y presin arterial, mientras que los que continuaron el tratamiento, lograron reducir el peso an ms
Ferrando AA, Sheffield-Moore M, Yeckel CW, et al
They can help you determine if it fits your specific health profile
"Even someone who needs to lose 30 pounds, they'll lose 10 pounds a month and then they won't lose too much," Billing told Insider